-
Jasper Therapeutics' (JSPR) "Buy" Rating Reaffirmed at HC Wainwright
ソース: Buzz FX / 15 10 2024 08:16:11 America/Chicago
Jasper Therapeutics' (JSPR) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat October 15, 2024 Share Link copied to clipboard. Jasper Therapeutics ( NASDAQ:JSPR - Get Free Report ) 's stock had its "buy" rating reissued by stoc
Read more...